136 related articles for article (PubMed ID: 28394299)
1. c-Jun Contributes to Transcriptional Control of GNA12 Expression in Prostate Cancer Cells.
Udayappan UK; Casey PJ
Molecules; 2017 Apr; 22(4):. PubMed ID: 28394299
[No Abstract] [Full Text] [Related]
2. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
[TBL] [Abstract][Full Text] [Related]
3. JUN-CCAAT/enhancer-binding protein complexes inhibit surfactant-associated protein B promoter activity.
Bein K; Leight H; Leikauf GD
Am J Respir Cell Mol Biol; 2011 Aug; 45(2):436-44. PubMed ID: 21148742
[TBL] [Abstract][Full Text] [Related]
4. The role of sLZIP in transcriptional regulation of c-Jun and involvement in migration and invasion of cervical cancer cells.
Park E; Kang H; Kim J; Ko J
Cell Physiol Biochem; 2014; 33(1):151-64. PubMed ID: 24481121
[TBL] [Abstract][Full Text] [Related]
5. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
6. Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism.
Sha Z; Zhu X; Li N; Li Y; Li D
Oncotarget; 2016 Oct; 7(40):64977-64986. PubMed ID: 27533465
[TBL] [Abstract][Full Text] [Related]
7. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
Zha S; Isaacs WB
Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells.
Rasheed SAK; Teo CR; Beillard EJ; Voorhoeve PM; Casey PJ
J Biol Chem; 2013 Mar; 288(11):7986-7995. PubMed ID: 23329838
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun.
Faggioli L; Costanzo C; Donadelli M; Palmieri M
Biochim Biophys Acta; 2004 May; 1692(1):17-24. PubMed ID: 15158360
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the rat CYP4A2 gene promoter by c-Jun and octamer binding protein-1.
Fiala-Beer E; Lee AC; Murray M
Int J Biochem Cell Biol; 2007; 39(6):1235-47. PubMed ID: 17481938
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
[TBL] [Abstract][Full Text] [Related]
14. c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer.
Cai C; Hsieh CL; Shemshedini L
Mol Cancer Res; 2007 Jul; 5(7):725-35. PubMed ID: 17634427
[TBL] [Abstract][Full Text] [Related]
15. Direct regulation of FOXK1 by C-jun promotes proliferation, invasion and metastasis in gastric cancer cells.
Peng Y; Zhang P; Huang X; Yan Q; Wu M; Xie R; Wu Y; Zhang M; Nan Q; Zhao J; Li A; Xiong J; Ren Y; Bai Y; Chen Y; Liu S; Wang J
Cell Death Dis; 2016 Nov; 7(11):e2480. PubMed ID: 27882939
[TBL] [Abstract][Full Text] [Related]
16. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.
Levy N; Zhao X; Tang H; Jaffe RB; Speed TP; Leitman DC
Endocrinology; 2007 Jul; 148(7):3449-58. PubMed ID: 17395694
[TBL] [Abstract][Full Text] [Related]
17. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
[TBL] [Abstract][Full Text] [Related]
18. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.
Marreiros A; Dudgeon K; Dao V; Grimm MO; Czolij R; Crossley M; Jackson P
Oncogene; 2005 Jan; 24(4):637-49. PubMed ID: 15580298
[TBL] [Abstract][Full Text] [Related]
19. Gα-13 induces C
Lim WK; Chai X; Ghosh S; Ray D; Wang M; Rasheed SAK; Casey PJ
J Biol Chem; 2019 Nov; 294(48):18192-18206. PubMed ID: 31636124
[TBL] [Abstract][Full Text] [Related]
20. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
Sanford DC; DeWille JW
Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
